Remarkable Regression of an Osteolytic Lesion of Large Cell Lung Cancer Treated with Zoledronic Acid: A Case Report

Zoledronic acid suppresses osteoclastic changes and reduces the risk of cancer-induced skeletal-related events. Moreover, it has been reported to have antitumor effects. The authors here present a case of a male patient with large cell lung cancer who had an osteolytic lesion in the thoracic vertebr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Sadayuki, Yamaura, Gengo, Yasuda, Katsuhiro, Suzuki, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: May, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369252/
https://www.ncbi.nlm.nih.gov/pubmed/22679429
http://dx.doi.org/10.1159/000339125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369252/
https://www.ncbi.nlm.nih.gov/pubmed/22679429
http://dx.doi.org/10.1159/000339125

Ejemplares similares